1. Home
  2. GDTC vs FGF Comparison

GDTC vs FGF Comparison

Compare GDTC & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • FGF
  • Stock Information
  • Founded
  • GDTC 2018
  • FGF 2012
  • Country
  • GDTC Singapore
  • FGF United States
  • Employees
  • GDTC N/A
  • FGF N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • FGF Property-Casualty Insurers
  • Sector
  • GDTC Health Care
  • FGF Finance
  • Exchange
  • GDTC Nasdaq
  • FGF Nasdaq
  • Market Cap
  • GDTC 28.0M
  • FGF 22.8M
  • IPO Year
  • GDTC 2023
  • FGF N/A
  • Fundamental
  • Price
  • GDTC $2.40
  • FGF $15.87
  • Analyst Decision
  • GDTC Buy
  • FGF
  • Analyst Count
  • GDTC 1
  • FGF 0
  • Target Price
  • GDTC $5.00
  • FGF N/A
  • AVG Volume (30 Days)
  • GDTC 32.5K
  • FGF 2.6K
  • Earning Date
  • GDTC 01-01-0001
  • FGF 05-19-2025
  • Dividend Yield
  • GDTC N/A
  • FGF N/A
  • EPS Growth
  • GDTC N/A
  • FGF N/A
  • EPS
  • GDTC N/A
  • FGF N/A
  • Revenue
  • GDTC $330,254.00
  • FGF $17,348,000.00
  • Revenue This Year
  • GDTC $14.71
  • FGF N/A
  • Revenue Next Year
  • GDTC N/A
  • FGF N/A
  • P/E Ratio
  • GDTC N/A
  • FGF N/A
  • Revenue Growth
  • GDTC N/A
  • FGF 1.49
  • 52 Week Low
  • GDTC $1.20
  • FGF $14.21
  • 52 Week High
  • GDTC $4.05
  • FGF $38.40
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 48.41
  • FGF 34.97
  • Support Level
  • GDTC $2.20
  • FGF $15.13
  • Resistance Level
  • GDTC $2.46
  • FGF $16.00
  • Average True Range (ATR)
  • GDTC 0.21
  • FGF 0.67
  • MACD
  • GDTC 0.01
  • FGF -0.07
  • Stochastic Oscillator
  • GDTC 34.67
  • FGF 17.80

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About FGF FG Financial Group Inc. (NV)

Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.

Share on Social Networks: